In vivo expansion of cells expressing acquired CSF3R mutations in patients with severe congenital neutropenia

Blood

Volumn 113, Issue 3, 2009, Pages 668-670

  Germeshausen, Manuela ^a   Welte, Karl ^a   Ballmaier, Matthias ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; COLONY STIMULATING FACTOR RECEPTOR; CSF3R PROTEIN, HUMAN;

ARTICLE; BONE MARROW CELL; CASE REPORT; CELL DIFFERENTIATION; CELL EXPANSION; CELL MATURATION; CELL SUBPOPULATION; CSF3R GENE; GENE; GENE EXPRESSION; GENE MUTATION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IN VIVO STUDY; LYMPHOID CELL; NEUTROPENIA; PRIORITY JOURNAL; ADOLESCENT; ADULT; CELL TRANSFORMATION; DISEASE COURSE; FLOW CYTOMETRY; GENETICS; LEUKEMIA; MUTATION; PRECANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADOLESCENT; ADULT; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; FLOW CYTOMETRY; HUMANS; LEUKEMIA; MUTATION; NEUTROPENIA; PRECANCEROUS CONDITIONS; RECEPTORS, COLONY-STIMULATING FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 60249083503     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-09-178087     Document Type: Article

References (12)

1. Rosenberg PS, Alter BP, Bolyard AA, et al. The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy. Blood. 2006; 107:4628-4635.
2. Germeshausen M, Ballmaier M,Welte K. Incidence of CSF3R mutations in severe congenital neutropenia and relevance for leukemogenesis: Results of a long-term survey. Blood. 2007;109:93-99.
3. Sauer S, Ballmaier M, Welte K, Germeshausen M. Acquired G-CSF receptor mutation in myeloid progenitor cells in a patient with acute myeloid leukemia secondary to congenital neutropenia [abstract]. Blood. 2003;102:276A.
4. Fukunaga R, Seto Y, Mizushima S, Nagata S. Three different mRNAs encoding human granulocyte colony-stimulating factor receptor. Proc Natl Acad Sci U S A. 1990;87:8702-8706.
5. Dong F, Hoefsloot LH, Schelen AM, et al. Identification of a nonsense mutation in the granulocytecolony- stimulating factor receptor in severe congenital neutropenia. Proc Natl Acad Sci U S A. 1994;91:4480-4484.
6. Bernard T, Gale RE, Evans JP, Linch DC. Mutations of the granulocyte-colony stimulating factor receptor in patients with severe congenital neutropenia are not required for transformation to acute myeloid leukaemia and may be a bystander phenomenon. Br J Haematol. 1998; 101:141-149.
7. Liu F, Kunter G, Krem MM, et al. Csf3r mutations in mice confer a strong clonal HSC advantage via activation of Stat5. J Clin Invest. 2008;118:946-955.
8. Germeshausen M, Ballmaier M, Schulze H, et al. Granulocyte colony-stimulating factor receptor mutations in a patient with acute lymphoblastic leukemia secondary to severe congenital neutropenia. Blood. 2001;97:829-830.
9. Cassinat B, Bellanne-Chantelot C, Notz-Carrere A, et al. Screening for G-CSF receptor mutations in patients with secondary myeloid or lymphoid transformation of severe congenital neutropenia: a report from the French neutropenia register. Leukemia. 2004;18:1553-1555.
10. Boneberg EM, Hareng L, Gantner F, Wendel A, Hartung T. Human monocytes express functional receptors for granulocyte colony-stimulating factor that mediate suppression of monokines and interferon-gamma. Blood. 2000;95: 270-276.
11. Dancey JT, Deubelbeiss KA, Harker LA, Finch CA. Neutrophil kinetics in man. J Clin Invest. 1976;58:705-715.
12. Bagby GC. Discovering early molecular determinants of leukemogenesis. J Clin Invest. 2008;118: 847-850.